Therapeutic Decision Making in a Case of Carcinoma Breast

Abstract

Carcinoma Breast is a clinically and pathologically heterogeneous disease. Carcinoma Breast is the most prevalent aggressive cancer in females and second major reason of mortality rate in after lung cancer of women. Parity compared to ER & PR status is found to be more ER/ PR negative as parity increases. This study is a prospective study conducted on 110 women with carcinoma breast done over a period from December 2016 to June 2018. Prognostic factors such as age, parity, menopausal status and histomorphological factors such as size of the tumor, tumor grade, histological type, axillary lymph node metastasis status was correlated with ER and PR status